Mark Tsai

Mark Tsai is an accomplished Senior Cell Therapy Account Specialist at Legend Biotech, recognized for outstanding performance with numerous awards, including two Hall of Legends Awards and the Essence of Legend Award. Mark specializes in the launch of Carvykti for relapsed/refractory multiple myeloma across leading CAR-T institutions. Previous roles include Field Sales Trainer and Senior Clinical Oncology Specialist at Puma Biotechnology, where Mark received multiple Circle of Excellence and Pinnacle Awards for exceptional sales performance. Mark's extensive experience in oncology sales spans positions at notable companies such as Bristol Myers Squibb, ALLOS Therapeutics, Novartis, Pfizer, and Bayer. Mark holds a Bachelor of Science degree in Biology from UC Irvine and an MBA in Business Management and Marketing from Pepperdine Graziadio Business School.